Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS-Reference-Cited by-同舟云学术

Depicting Risperidone Safety Profiles in Clinical Trials Across Different Diagnoses Using a Dopamine D2-Based Pharmacological Class Effect Query Defined by FAERS

Published:2022-11-09 Issue:12 Volume:42 Page:1113-1121
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clin Drug Investig

Author:

Hopkins Seth C.^ORCID,Ogirala Ajay,Zeni Courtney,Worden MaryAlice,Koblan Kenneth S.

Funder

Sunovion

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s40261-022-01218-7.pdf

Reference38 articles.

1. Owen MJ, Sawa A, Mortensen PB. Schizophrenia. Lancet. 2016;388(10039):86–97. https://doi.org/10.1016/S0140-6736(15)01121-6.

2. Correll CU, Rubio JM, Kane JM. What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia? World Psychiatry. 2018;17:149–60. https://doi.org/10.1002/wps.20516.

3. Correll CU, Martin A, Patel C, Benson C, Goulding R, Kern-Sliwa J, et al. Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics. NPJ Schizophr. 2022;8:5. https://doi.org/10.1038/s41537-021-00192-x.

4. Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG, et al. Risk factors for relapse following treatment for first episode psychosis: a systematic review and meta-analysis of longitudinal studies. Schizophr Res. 2012;139:116–28. https://doi.org/10.1016/j.schres.2012.05.007.

5. Ostuzzi G, Bertolini F, Tedeschi F, Vita G, Brambilla P, Del Fabro L, et al. Oral and long-acting antipsychotics for relapse prevention in schizophrenia-spectrum disorders: a network meta-analysis of 92 randomized trials including 22,645 participants. World Psychiatry. 2022;21:295–307. https://doi.org/10.1002/wps.20972.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical drug interactions between linezolid and other antibiotics: For adverse drug event monitoring;Pharmacology Research & Perspectives;2024-07-24

2. Research Progress on the Clinical Effect and Economy of Risperidone in the Treatment of Schizophrenia;Advances in Clinical Medicine;2024

3. A Novel Method for Deriving Adverse Event Prevalence in Randomized Controlled Trials: Potential for Improved Understanding of Benefit-Risk Ratio and Application to Drug Labels;Advances in Therapy;2023-10-19

4. Ulotaront: review of preliminary evidence for the efficacy and safety of a TAAR1 agonist in schizophrenia;European Archives of Psychiatry and Clinical Neuroscience;2023-05-10